Skip to main content

Pathology tests database

Back to Clinical Biochemistry

Infliximab (Inflectra)

Clinical Biochemistry

Sample and container requirements

Serum SST (preferred) EDTA Plasma Lithium Heparin Plasma (paediatrics only) Citrate Plasma

Minimum volume required

300 μL serum/plasma

Special requirements

If transport is going to be delayed by > 5 days, freeze at -20°C and send by first class post at a later date.

Patient preparation

Trough sample preferred.

Sample viability

Turnaround time

21 days

Reference range

Please refer to report for reference ranges.

Clinical guidance

Please follow the link below to the referral laboratory website for more information: https://synlab.co.uk/test-database/infliximab-remicade-remsima-inflectra/

Notes

Sent to Synnovis (St Thomas' Hospital)

Images to go here

This information was last updated on 19 August 2026